Skip to content

Clinical trials

Observational Overweight trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Phase: Observational Clear all

422 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20041
20054
20063
200710
200810
200911
20107
201110
201216
20138
201417
201510
201617
201714
201819
201919
202022
202117
202219
202332
202435
202557
202654

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed206
Unknown status62
Recruiting61
Not yet recruiting36
Active, not recruiting30
Enrolling by invitation11
Terminated8
Withdrawn7
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S15
John Sievenpiper12
Brigham and Women's Hospital5
Maastricht University Medical Center5
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)5
Universitaire Ziekenhuizen KU Leuven5
Central Hospital, Nancy, France4
Duke University4
Massachusetts General Hospital4
Pennington Biomedical Research Center4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight422
Obesity376
Diabetes Mellitus, Type 242
Metabolic Syndrome41
Diabetes Mellitus36
Hypertension33
Weight Loss30
Insulin Resistance29
Body Weight25
Cardiovascular Diseases23

Trials

Showing 1 to 25 of 422. Each trial links to its page on Pharma Observatory.

322 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.